Patent holdings for IPC class A61K 39/00

Total number of patents in this class: 48259

10-year publication summary

3073
3637
4091
4009
3896
3977
3442
2793
4667
2379
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Immatics Biotechnologies GmbH
1152
888
The Regents of the University of California
19812
564
Regeneron Pharmaceuticals, Inc.
4223
555
The Trustees of the University of Pennsylvania
4308
508
Glaxosmithkline Biologicals S.A.
1636
490
Genentech, Inc.
3961
468
The United States of America, as represented by the Secretary, Department of Health and Human Services
2837
464
Novartis AG
10904
429
Janssen Biotech, Inc.
1531
315
The Board of Trustees of the Leland Stanford Junior University
6365
309
Amgen Inc.
4047
306
Memorial Sloan-Kettering Cancer Center
1910
306
Board of Regents, The University of Texas System
5751
276
Hoffmann-La Roche Inc.
3379
270
Inserm (institut National de La Sante et de La Recherche Medicale)
3360
259
Bristol-myers Squibb Company
4892
255
Dana-Farber Cancer Institute, Inc.
2553
249
Pfizer Inc.
3367
236
The General Hospital Corporation
4704
203
The Johns Hopkins University
5642
200
Other owners 40709